Durable Complete Response of Colorectal Cancer Metastasis after Biochemotherapy

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10361215" target="_blank" >RIV/00216208:11110/17:10361215 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11140/17:10361215 RIV/00669806:_____/17:10361215 RIV/00023884:_____/12:00007288 RIV/00064190:_____/17:N0000005

Result on the web

<a href="https://www.linkos.cz/files/klinicka-onkologie/214/5174.pdf" target="_blank" >https://www.linkos.cz/files/klinicka-onkologie/214/5174.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.14735/amko2017210" target="_blank" >10.14735/amko2017210</a>

Result language

angličtina

Original language name

Durable Complete Response of Colorectal Cancer Metastasis after Biochemotherapy

Original language description

Background: Resection of the metastatic site is indicated but not always possible in patients with metastatic colorectal cancer (mCRC) who achieve a partial or complete response (CR) to induction systemic treatment. CR after systemic treatment alone is uncommon, and even patients with radiologic CR after induction chemotherapy harbour persistent macroscopic or microscopic residual disease in more than 80% of cases. Occasionally, some metastatic lesions disappear radiologically but others persist after induction systemic treatment. The indication and extent of metastasectomy in these situations is controversial, especially regarding sites with completely regressed metastases. Case: This case report describes a patient with mCRC who achieved a long-term response after biochemotherapy and incomplete metastasectomy. One of the known liver lesions could not be removed due to its disappearance after induction biochemotherapy with FOLFOX and bevacizumab. Further adjuvant chemotherapy using the FOLFOX regimen was administered postoperatively. The patient has been meticulously followed by radiology including repeated positron emission tomography/computed tomography and magnetic resonance scans, clinical examination and tumour markers. No recurrence of cancer has been detected after a follow-up of 5 years. Results and Conclusion: CR to systemic treatment is uncommon, but this case report demonstrates that it can be durable in patients with colorectal cancer and liver metastases. This case report indicates that some patients with mCRC can be cured with systemic therapy only, challenging the prevailing paradigm of mCRC therapy.

Czech name

—

Czech description

—

Type

J_SC - Article in a specialist periodical, which is included in the SCOPUS database

CEP classification

—

OECD FORD branch

30204 - Oncology

Project

<a href="/en/project/NV15-26535A" target="_blank" >NV15-26535A: The role of genetic variations in microRNA genes and in microRNA binding sites in colorectal cancer in relation to personalized therapy</a><br>

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Klinická onkologie

ISSN

0862-495X

e-ISSN

—

Volume of the periodical

30

Issue of the periodical within the volume

3

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

3

Pages from-to

210-212

UT code for WoS article

—

EID of the result in the Scopus database

2-s2.0-85020507721